Drugs / Anti-BAFFR CART
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06561009 | Dec 2025 → Oct 2027 expected | neuromyelitis optica | Tianjin Medical University General Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-BAFFR CART | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06561009 ↗ |
| Modality | Cell therapy | “BAFFR CART cells” NCT06561009 ↗ |